Home > News
News
TFDA approves GSH-BGM903 Blood Glucose Monitoring System
2018/3/15
The Taiwan Food and Drug Administration last mouth approved the GSH-BGM903 Blood Glucose Monitoring System, the glucose monitoring system that can be used by adult patients to record diabetes treatment result with Bluetooth technology .
The system reduces the need for paper work by using Bluetooth technology. Users can determine glucose levels by checking the WowGoHealth APP if glucose levels are too high (hyperglycemia) or too low (hypoglycemia), and how glucose levels are changing.
The WowGoHealth Blood Glucose Monitoring System (Model GSH-BGM903) consists of the WowGoHealth Blood Glucose Monitor and the WowGoHealth Blood Glucose Test Strip. The WowGoHealth Blood Glucose Monitoring System (Model GSH-BGM903) is intended to be used for the quantitative measurement of glucose in fresh capillary whole blood drawn from the fingertips or forearm. The WowGoHealth Blood Glucose Monitoring System (Model GSH-BGM903) is intended for self-testing outside the body (in vitro diagnostic use) by people with diabetes at home as an aid in monitoring the effectiveness of a diabetes control program.
The system reduces the need for paper work by using Bluetooth technology. Users can determine glucose levels by checking the WowGoHealth APP if glucose levels are too high (hyperglycemia) or too low (hypoglycemia), and how glucose levels are changing.
The WowGoHealth Blood Glucose Monitoring System (Model GSH-BGM903) consists of the WowGoHealth Blood Glucose Monitor and the WowGoHealth Blood Glucose Test Strip. The WowGoHealth Blood Glucose Monitoring System (Model GSH-BGM903) is intended to be used for the quantitative measurement of glucose in fresh capillary whole blood drawn from the fingertips or forearm. The WowGoHealth Blood Glucose Monitoring System (Model GSH-BGM903) is intended for self-testing outside the body (in vitro diagnostic use) by people with diabetes at home as an aid in monitoring the effectiveness of a diabetes control program.
